Abstract
Nanoparticles have long been sought as promising drug delivery system for cancer therapy, including liposomes, polymeric micelles, polymer-drug conjugates, dendrimers and polymeric nanoparticles. However, conventional nanoparticles would be specifically entrapped by the monocyte phagocytic system (MPS), and then quickly eliminated following intravenous administration, so the applications of nanoparticles are limited due to short circulation lifetime. Since long-circulation property is the prerequisite for nanoparticles reaching the target site of interest, the nanoparticle surface is usually modified by hydrophilic polymer materials such as PEG, to reduce plasma opsonization and MPS uptake. Furthermore, increased tumor specificity and cell internalization will improve the treatment efficacy and decrease the serious side effects for many cytotoxic antineoplastic drugs. Introducing the targeting ligands for interaction with specific tumor cells or tissues will offer major enhancement in cancer therapeutics via site specificity, reduction of multidrug resistance and improved delivery efficiency. This article will give an overview on the current state of long-circulating nanoparticles and describe their major advantages and potential pitfalls. Special emphasis is placed on the superiority of long-circulating nanoparticles used for tumor targeting.
Keywords: Nanoparticles, targeted drug delivery, long-circulating nanoparticles, cancer therapy
Current Nanoscience
Title: Long-circulating Targeted Nanoparticles for Cancer Therapy
Volume: 6 Issue: 4
Author(s): Yang Liu, Jin Sun, Jihong Han and Zhonggui He
Affiliation:
Keywords: Nanoparticles, targeted drug delivery, long-circulating nanoparticles, cancer therapy
Abstract: Nanoparticles have long been sought as promising drug delivery system for cancer therapy, including liposomes, polymeric micelles, polymer-drug conjugates, dendrimers and polymeric nanoparticles. However, conventional nanoparticles would be specifically entrapped by the monocyte phagocytic system (MPS), and then quickly eliminated following intravenous administration, so the applications of nanoparticles are limited due to short circulation lifetime. Since long-circulation property is the prerequisite for nanoparticles reaching the target site of interest, the nanoparticle surface is usually modified by hydrophilic polymer materials such as PEG, to reduce plasma opsonization and MPS uptake. Furthermore, increased tumor specificity and cell internalization will improve the treatment efficacy and decrease the serious side effects for many cytotoxic antineoplastic drugs. Introducing the targeting ligands for interaction with specific tumor cells or tissues will offer major enhancement in cancer therapeutics via site specificity, reduction of multidrug resistance and improved delivery efficiency. This article will give an overview on the current state of long-circulating nanoparticles and describe their major advantages and potential pitfalls. Special emphasis is placed on the superiority of long-circulating nanoparticles used for tumor targeting.
Export Options
About this article
Cite this article as:
Liu Yang, Sun Jin, Han Jihong and He Zhonggui, Long-circulating Targeted Nanoparticles for Cancer Therapy, Current Nanoscience 2010; 6 (4) . https://dx.doi.org/10.2174/157341310791658991
DOI https://dx.doi.org/10.2174/157341310791658991 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
Call for Papers in Thematic Issues
Role of nanomaterials in fabrication of coatings, Machining and Joining
The application of nanoscience has brought about a revolution in the field of mechanical engineering by providing novel materials, boosting manufacturing processes, and generating cutting-edge products. The purpose of this special issue is to investigate the enormous impact that nanoscience has had on mechanical engineering, with a particular emphasis on ...read more
Advanced Inorganic Nanocomposites and Their Emerging Applications
This special issue collection will highlight developments on the recent trends about the synthesis of metal oxides, nanoclusters, biomaterials, 2D nanomaterials, nanocrystals, nanocomposites, etc. and their applications in electrochemical systems, tissue regeneration, energy storage and harvesting, sensors, etc. The novelty of the methods in the chemical synthesis and their characterizations, ...read more
Applicability of Nanotechnology for Performance Enhancement of Clean Energy Technologies
Population growth, industrialization, and improvement in living quality would lead to further increase in energy demand in near future. Regarding the disadvantages of fossil fuels such as fluctuations in their price, high emissions of greenhouse gases and restriction of their sources, it is crucial to use and exploit alternative energy ...read more
Graphene and 2D Materials for Energy Storage and Conversion
This thematic issue will discuss the recent advances in graphene-based nanomaterials for different energy technologies. Graphene possesses a high surface area, and stable structure and exhibits many interesting electronic, optical, and mechanical properties due to its 2D crystal structure. Graphene is of both fundamental interest and suitable for a wide ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cardiovascular Pharmacogenetics of Antihypertensive and Lipid- Lowering Therapies
Current Molecular Medicine Preclinical Development of New Therapy for Glycogen Storage Diseases
Current Gene Therapy Editorial [News in Therapy of Cardiomyopathy (Executive Editor: Giovanni Fazio)]
Current Pharmaceutical Design Current Pharmacologic Management of Pediatric Heart Failure in Congenital Heart Disease
Current Vascular Pharmacology Stem Cell Therapy for the Treatment of Acute Myocardial Infarction and Chronic Ischemic Heart Disease
Current Pharmaceutical Biotechnology Potential Treatment of Cardiac Hypertrophy and Heart Failure by Inhibiting the Sarcolemmal Binding of Phospholipase Cβ1b
Current Drug Targets Ectodomain Shedding of ACE and ACE2 as Regulators of Their Protein Functions
Current Enzyme Inhibition Cardiac and Metabolic Consequences of Aerobic Exercise Training in Experimental Diabetes
Current Diabetes Reviews Contextualizing Genetics for Regional Heart Failure Care
Current Cardiology Reviews Apelin in the Control of Body Fluid Homeostasis and Cardiovascular Functions
Current Pharmaceutical Design Cellular Cardiomyoplasty – Challenges of a New Era
Current Tissue Engineering (Discontinued) The Potential Role of Sirtuins Regarding the Effects of Exercise on Aging- Related Diseases
Current Aging Science Myocardial Revascularization for the Elderly: Current Options, Role of Off-pump Coronary Artery Bypass Grafting and Outcomes
Current Cardiology Reviews Antimicrobial Agents-Associated with QT Interval Prolongation
Current Drug Safety Cardiovascular Proteomics
Current Proteomics Interactive Effect of Combined Exposure to Active and Passive Smoking on Cardiovascular System
Recent Patents on Cardiovascular Drug Discovery The STAT3 Inhibitor Stattic Impairs Cardiomyocyte Mitochondrial Function Through Increased Reactive Oxygen Species Formation
Current Pharmaceutical Design Pediatric Heart Failure in the Developing World
Reviews on Recent Clinical Trials Editorial: [Hot Topic: Chromogranin A at the Crossroads of Health and Disease]
Current Medicinal Chemistry Animal Models Used for the Evaluation of Antiretroviral Therapies
Current HIV Research